Abiomed Revenue and Competitors
Estimated Revenue & Valuation
- Abiomed's estimated annual revenue is currently $973.6M per year.
- Abiomed received $41.7M in venture funding in August 2008.
- Abiomed's estimated revenue per employee is $459,048
- Abiomed's total funding is $40M.
- Abiomed's current valuation is $13.7B. (January 2022)
Employee Data
- Abiomed has 2121 Employees.
- Abiomed grew their employee count by 23% last year.
Abiomed's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | Executive Assistant to VP | Reveal Email/Phone |
3 | Area VP - Mountain | Reveal Email/Phone |
4 | VP | Reveal Email/Phone |
5 | Area VP | Reveal Email/Phone |
6 | Chief Medical Officer, VP Global Clinical and Medical Affairs | Reveal Email/Phone |
7 | Area VP Sales | Reveal Email/Phone |
8 | Area VP, Atlantic Coast | Reveal Email/Phone |
9 | VP and General Counsel, VP Business Development | Reveal Email/Phone |
10 | Chief Operations | Reveal Email/Phone |
Abiomed Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.8M | 39 | 3% | N/A | N/A |
#2 | $8.5M | 34 | 3% | N/A | N/A |
#3 | $3M | 12 | -29% | N/A | N/A |
#4 | $5630M | 7477 | -11% | $450M | N/A |
#5 | $4.5M | 18 | 6% | N/A | N/A |
#6 | $7.2M | 57 | 27% | $29.6M | N/A |
#7 | $14.3M | 57 | -12% | N/A | N/A |
#8 | $2.3M | 18 | 6% | $44M | N/A |
#9 | $40.7M | 162 | -1% | N/A | N/A |
#10 | $45.7M | 182 | -5% | N/A | N/A |
What Is Abiomed?
Abiomed (NASDAQ: ABMD) is a pioneer and global leader in healthcare technology and innovation, with a mission of RECOVERING HEARTS AND SAVING LIVES. Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company's efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company's portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world's first total replacement heart to the World's Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.
keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals
$40M
Total Funding
2121
Number of Employees
$973.6M
Revenue (est)
23%
Employee Growth %
$13.7B
Valuation
N/A
Accelerator
Abiomed News
Shares of Abiomed Inc. ABMD, -1.49% shed 1.49% to $301.51 Monday, on what proved to be an all-around grim trading session for the stock...
This illustration shows the Impella 5.5 with SmartAssist placed in the heart. [Image courtesy of Abiomed] Abiomed (Nasdaq:ABMD) announced today...
Based in Danvers, Massachusetts, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support. Our products are...
"Our biggest challenge was not maintaining production and operations during the pandemic - but it's today, managing the impact of the aftershocks."- Joanne Mavroides, Director Supply Chain & Logistics at Abiomed The medtech industry association, MassMEDIC, recently held a "Virtual Supplier Show ...
Other Companies in Danvers
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $932.2M | 2786 | 38% | N/A |
Abiomed Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2008-08-25 | $41.7M | Undisclosed | Morgan Stanley and Company | Article |